MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-TS-02-0022592
Rakshit Pharmaceuticals Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹238.14 Cr
▼ 6% YoY
Net profit · FY 2024
₹3.49 Cr
Net margin 1.5%
EBITDA · FY 2024
₹14.22 Cr
EBITDA margin 6%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹4.21 Cr
Issued & subscribed
Open charges
₹93.43 Cr
Satisfied ₹34.9 Cr
Company age
21 yrs
Est. 2005
Employees · EPFO
61
Provident fund records
About Rakshit Pharmaceuticals Limited
Data last updated:
Rakshit Pharmaceuticals Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 23 November 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2005PLC048151. Its GSTIN is 37AADCR1986L1ZT (Andhra Pradesh).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.21 Cr. It is led by directors including Palem Srinivas (Managing Director) and Anjaneya Pattabhi Rameswara Rao Chandana.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹238.14 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹3.49 Cr (net margin 1.5%) and EBITDA of ₹14.22 Cr (EBITDA margin 6%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years.
The company has about 61 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹93.43 Cr and satisfied charges of ₹34.9 Cr on record. Court records list 19 cases involving the company, including 17 filed by the company and 2 filed against it; 4 cases are pending. The company has 11 deals on record (6 funding rounds, 5 secondary share transfers), with disclosed funding of ₹9.3 Cr; the latest was in August 2018. Its 10 peer companies in the Pharma industry (API Manufacturers, Pharmaceuticals) are compared by revenue, 5 larger and 5 smaller; the largest is Lucky Pharmaceuticals Private Limited with revenue of ₹261.97 Cr.
Rakshit Pharmaceuticals Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0022592). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rakshitdrugspvtltd.com.
Company Details of Rakshit Pharmaceuticals Limited
CIN U24239TG2005PLC048151
Registration Number 048151
Incorporation Date 23 November 2005
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-02-0022592
CIN History of Rakshit Pharmaceuticals Limited
Rakshit Pharmaceuticals has one previous CIN (Corporate Identification Number): U24239AP2005PLC048151. The current CIN is U24239TG2005PLC048151, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2005PLC048151 | Current |
| U24239AP2005PLC048151 | Previous |
Key People
Palem Srinivas Managing Director Anjaneya Pattabhi Rameswara Rao Chandana Director Aruna Kumari Chandana Director Recognitions & Rankings of Rakshit Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlotno28 4th&5 Thfloors Sector III, Hudatechnoenclave Madhapur, Hyderabad, Telangana, India – 500081
- IndustryPharma, API Manufacturers
Comprehensive company report
Rakshit Pharmaceuticals Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Rakshit Pharmaceuticals Limited
The main business activity of Rakshit Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Rakshit Pharmaceuticals Limited FY 2024 filings available
Rakshit Pharmaceuticals Limited reported revenue of ₹238.14 Cr (down 6% YoY) for FY 2024.
Revenue · FY 2024
₹238.14 Cr ▼ 6%
Net profit · FY 2024
₹3.49 Cr margin 1.5%
EBITDA · FY 2024
₹14.22 Cr margin 6%
Compounded Annual Growth Rate (CAGR) of Rakshit Pharmaceuticals Limited
Revenue CAGR growth
1 year
▼ 6%
3 years · compounded
▼ 4%
EBITDA CAGR growth
1 year
▼ 10%
3 years · compounded
▼ 21%
5 years · compounded
▼ 5%
Revenue has declined at a compounded annual rate (CAGR) of 4% over three years, including a 6% fall in the latest year. EBITDA fell 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Rakshit Pharmaceuticals Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹14.22 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.49 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Rakshit Pharmaceuticals Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Rakshit Pharmaceuticals are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Rakshit Pharmaceuticals Limited
Rakshit Pharmaceuticals has 4 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Palem Srinivas | Managing Director | 07 Mar 2009 | 17 Years 7 Months | Current |
| Anjaneya Pattabhi Rameswara Rao Chandana Also directs: Organor Chemicals LLP, Rakshit Drugs Private Limited, Srisaichandana Api Private Limited and 5 more | Director | 23 Nov 2005 | 20 Years 10 Months | Current |
| Aruna Kumari Chandana Also directs: Rakshit Drugs Private Limited, Azico Biophore India Private Limited, Rakshit Research Centre Private Limited and 1 more | Director | 23 Nov 2005 | 20 Years 10 Months | Current |
| Veera Venkata Vara Prasad Veerni | Director | 17 Feb 2020 | 6 Years 8 Months | Current |
Peer Comparison of Rakshit Pharmaceuticals Limited
Rakshit Pharmaceuticals Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lucky Pharmaceuticals Private Limited | ₹261.97 Cr (FY 2021) | •••• | •••• | -10.0% | •••• | Hyderabad, Telangana, India |
| Styrax Pharma Private Limited | ₹260.24 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | Visakhapatnam, Andhra Pradesh, India |
| Rakshit Drugs Private Limited | ₹256.13 Cr (FY 2024) | •••• | •••• | -3.0% | •••• | Hyderabad, Telangana, India |
| Shodhana Laboratories Private Limited | ₹250.16 Cr (FY 2024) | •••• | •••• | -23.0% | •••• | Hyderabad, Telangana, India |
| East India Pharmaceutical Works Limited | ₹249.94 Cr (FY 2024) | •••• | •••• | •••• | Kolkata, West Bengal, India | |
| Rakshit Pharmaceuticals Limited this company | ₹238.14 Cr (FY 2024) | •••• | •••• | -6.0% | •••• | Hyderabad, Telangana, India |
| Century Pharmaceuticals Limited | ₹234.99 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Vadodara, Gujarat, India |
| Delta Finochem Private Limited | ₹234.28 Cr (FY 2025) | •••• | •••• | -18.0% | •••• | Nashik, Maharashtra, India |
| Hy-Gro Chemicals Pharmtek Private Limited | ₹233.66 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Sangareddy, Telangana, India |
| Ferring Pharmaceuticals Private Limited | ₹233.5 Cr (FY 2024) | •••• | •••• | 7.0% | •••• | Mumbai, Maharashtra, India |
| Dosch Pharmaceuticals Private Limited | ₹229.86 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Rakshit Pharmaceuticals by revenue in the Pharma industry (API Manufacturers, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Rakshit Pharmaceuticals Limited
Rakshit Pharmaceuticals Limited is audited by Ramanatham & Rao for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Ramanatham & Rao | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Rakshit Pharmaceuticals Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Rakshit Pharmaceuticals Limited
Open charges
₹93.43 Cr
Satisfied charges
₹34.9 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Oct 2025 | Others | ₹7.26 Cr | Open |
| 28 Dec 2015 | Others | ₹86.17 Cr | Open |
| 14 Aug 2013 | Kotak Mahindra Bank Limited | ₹10 Lakh | Satisfied |
| 25 Aug 2011 | Icici Bank Limited | ₹16.5 Cr | Satisfied |
| 25 Aug 2011 | Icici Bank Limited | ₹11.1 Cr | Satisfied |
Total charge records: 6 View all charges
Deals & Funding of Rakshit Pharmaceuticals Limited
Rakshit Pharmaceuticals Limited has 11 deals on record (6 funding rounds, 5 secondary share transfers), with disclosed funding of ₹9.3 Cr; the latest was in August 2018.
Total deals
11
Funding rounds
6
Secondary share transfers
5
Disclosed funding
₹9.3 Cr
Deals on record (5 of 11)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2017 | Funding round | ₹1.25 Cr | Investors: Rakshit Drugs Private Limited |
| Sep 2011 | Funding round | ₹4 Cr | Investors: Rakshit Drugs Private Limited , an individual |
| Sep 2009 | Secondary share transfer | Undisclosed | Buyer: Rakshit Drugs Private Limited , an individual Seller: Revon Consultancy & Management Services Private Limited , Ramco Properties Private Limited , Bhagulvani Trading & Investments Private Limited |
| Apr 2009 | Secondary share transfer | Undisclosed | Buyer: Rakshit Drugs Private Limited , an individual Seller: 2 individuals |
| Apr 2009 | Secondary share transfer | Undisclosed | Buyer: Rakshit Drugs Private Limited , 3 individuals Seller: 2 individuals |
Premium access
Full deal history
All 11 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Rakshit Pharmaceuticals Limited
Rakshit Pharmaceuticals Limited has 19 court cases on record: 17 filed by Rakshit Pharmaceuticals, 2 filed against it. 4 cases are pending and 15 are disposed.
Total cases
19
Filed by the company
17
Filed against the company
2
Pending
4
Disposed
15
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 0 | 4 |
| High courts | 8 | 1 | 0 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 19)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against Eastern Power Distribution Company of Andhra Pradesh Ltd., and 1 other | Disposed |
| District court, Hyderabad Central, Telangana | Court case (CC - NI) | Filed by the company against M/S. Morepen Laboratories Limited (Unit-V) Rep.By M.D., Shri Sushil Suri and 5 others | Disposed |
| District court, Hyderabad Central, Telangana | Criminal complaint | Filed by the company against M/S. Morepen Laboratories Limited (Unit-V) Rep.By M.D., Shri Sushil Suri and 5 others | Disposed |
| District court, Hyderabad CCC, Telangana | Civil suit | Filed by the company against M/S. Magbro Health Care Private Limited | Disposed |
| District court, Hyderabad CCC, Telangana | Civil suit | Filed by the company against R.T. Pharma | Pending |
Premium access
Full case history
All 19 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Rakshit Pharmaceuticals Limited
Rakshit Pharmaceuticals Limited has a workforce of 61 employees as of Apr 05, 2024.
Employee count
61
Active EPFO establishments
1
Employee growth
-1.61%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Rakshit Pharmaceuticals Limited
Rakshit Pharmaceuticals Limited has 14 board changes on record since 2005: 4 appointments and 10 cessations. The latest: Sammeta Leela Venkata Nancharaiah ceased to be Whole-Time Director on 10 May 2022.
Charges
A charge with Others amounted to Rs. 7.26 Cr with Charge ID 101182824 was registered on 16 Oct 2025.
Charges
A charge with Others of Rs. 7.26 Cr registered on 16 Oct 2025 with Charge ID 101182824 was modified on 16 Oct 2025.
Charges
A charge with Others of Rs. 86.17 Cr registered on 28 Dec 2015 with Charge ID 10626018 was modified on 29 Jul 2025.
AGM
Rakshit Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Rakshit Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Ceased
Sammeta Leela Venkata Nancharaiah ceased to be Whole-Time Director.
Ceased
Bhavani Sankar Alla ceased to be Additional Director.
Ceased
Veera Venkata Vara Prasad Veerni ceased to be Additional Director.
Appointed
Veera Venkata Vara Prasad Veerni was appointed as Director.
Charges
A charge registered on 14 Aug 2013 via Charge ID 10448165 with Kotak Mahindra Bank Limited was fully satisfied on 31 Jan 2017.
Charges
A charge registered on 25 Aug 2011 via Charge ID 10304005 with Icici Bank Limited was fully satisfied on 24 Feb 2016.
Charges
A charge with Others amounted to Rs. 86.17 Cr with Charge ID 10626018 was registered on 28 Dec 2015.
19 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Rakshit Pharmaceuticals Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Rakshit Pharmaceuticals Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Rakshit Pharmaceuticals Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Rakshit Pharmaceuticals Limited
Rakshit Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AADCR1986L1ZT | Andhra Pradesh | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Rakshit Pharmaceuticals Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rakshit Pharmaceuticals Limited
Rakshit Pharmaceuticals is an active public limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 23 November 2005 (21+ years old) and is registered under CIN U24239TG2005PLC048151.
Rakshit Pharmaceuticals reported revenue of ₹238.14 Cr for FY 2024 (down 6% YoY).
Rakshit Pharmaceuticals has 4 current directors:
- Palem Srinivas - Managing Director
- Anjaneya Pattabhi Rameswara Rao Chandana - Director
- Aruna Kumari Chandana - Director
- Veera Venkata Vara Prasad Veerni - Director
Rakshit Pharmaceuticals reported a net profit of ₹3.49 Cr (net margin 1.5%) and EBITDA of ₹14.22 Cr (EBITDA margin 6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Rakshit Pharmaceuticals is -4% over three years. In the latest year (FY 2024) revenue fell 6%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Rakshit Pharmaceuticals is 37AADCR1986L1ZT, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Rakshit Pharmaceuticals is U24239TG2005PLC048151. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rakshit Pharmaceuticals has 19 court cases on record: 17 filed by the company and 2 filed against it. 4 are pending. Most are in the district courts.
Rakshit Pharmaceuticals was incorporated on 23 November 2005, making it 21+ years old. It is registered with the Registrar of Companies, Hyderabad.
Rakshit Pharmaceuticals has 11 deals on record (6 funding rounds, 5 secondary share transfers), with disclosed funding of ₹9.3 Cr; the latest was in August 2018.
The peers of Rakshit Pharmaceuticals by revenue are Lucky Pharmaceuticals Private Limited, Styrax Pharma Private Limited, Rakshit Drugs Private Limited, Shodhana Laboratories Private Limited, East India Pharmaceutical Works Limited and 5 more, all in the Pharma industry (API Manufacturers, Pharmaceuticals).